Delivery Order SPE2DB20D3103-SPE2DB24FQ1S2

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,611.86 delivery order is for Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The IDC has a ceiling value of $999,999,999 and runs through November 2026, providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens. The contract has a total ceiling value of $12,898.98 and is a Firm Fixed Price contract running through May 30, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,798.72, is for the procurement of Ozempic 0.25-0.5 mg/dose pens. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order issued under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $7,833.25 firm fixed-price order is for the supply of Ozempic 0.25-0.5 mg/dose pens, a medication used for diabetes management. The IDC, valued at $999,999,999, serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order is for the specialty medication Ozempic (0.25-0.5 mg/dose pen, 3 mL), with a ceiling value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,989.58 firm fixed-price contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a ceiling value of $2,738.89. The IDC is valued up to $999,999,999 and runs through December 2025, enabling DLA to efficiently procure a comprehensive range of medical commodities to support military treatment programs...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ozempic 0.25-0.5 mg/dose pens, a medication used to treat diabetes. The contract has a ceiling value of $28,067.62 and a performance period ending on May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, that provides a...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for diabetes management. The delivery order has a ceiling value of $1,879.98 and a completion date of February 5, 2025. This contract does not have a set-aside designation, indicating it was...
This is a delivery order under a broader Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $5,853.31 order is for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml, a medication used to treat diabetes. The delivery order has a firm fixed price and is set to be completed by November 25, 2024. AmerisourceBergen holds a $999,999,999 IDC with the DLA Troop Support Medical...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FQ1S2
    Delivery Order

This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens, a medication used for the treatment of diabetes. The delivery order has a ceiling value of $11,945.58 and a completion date of September 6, 2024. This order is part of a larger $999,999,999 IDC held by AmerisourceBergen with the DLA, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 10:58 AM